BioAmber (BIOA) Misses Q3 EPS by 16c

BioAmber (NYSE: BIOA) reported Q3 EPS of ($0.16), $0.16 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $3.3 million versus the consensus estimate of $6.75 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
• Sprinklr (CXM) Tops Q1 EPS by 1c ; Offers Guidance